Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33,235,472
-
Total 13F shares
-
12,690,314
-
Share change
-
+237,171
-
Total reported value
-
$130,836,764
-
Price per share
-
$10.31
-
Number of holders
-
41
-
Value change
-
+$2,444,618
-
Number of buys
-
31
-
Number of sells
-
9
Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q4 2023
As of 31 Dec 2023,
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,690,314 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, MORGAN STANLEY, Soleus Capital Management, L.P., Nantahala Capital Management, LLC, Kent Lake Capital LLC, FMR LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.